Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1978 Sep;129(3):210–224.

Medical staff conference. Paget disease of bone.

PMCID: PMC1238313  PMID: 100971

Full text

PDF
210

Images in this article

213Figure 1.
on p.213
213Figure 2.
on p.213
214Figure 3.
on p.214
214Figure 4.
on p.214
222Figure 5.
on p.222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRIGHT F., HENNEMAN P. H. The suppression of Paget's disease with ACTH and cortisone. Trans Assoc Am Physicians. 1955;68:238–246. [PubMed] [Google Scholar]
  2. Ajlouni K., Theil G. B. Mithramycin effects on calcium, phosphorus and parathyroid hormone in osseous Paget's disease. Am J Med Sci. 1975 Jan-Feb;269(1):13–18. doi: 10.1097/00000441-197501000-00002. [DOI] [PubMed] [Google Scholar]
  3. Altman R. D., Johnston C. C., Khairi M. R., Wellman H., Serafini A. N., Sankey R. R. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med. 1973 Dec 27;289(26):1379–1384. doi: 10.1056/NEJM197312272892601. [DOI] [PubMed] [Google Scholar]
  4. Avioli L. V., Berman M. Role of magnesium metabolism and the effects of fluoride therapy in Paget's disease of bone. J Clin Endocrinol Metab. 1968 May;28(5):700–710. doi: 10.1210/jcem-28-5-700. [DOI] [PubMed] [Google Scholar]
  5. Avramides A., Flores A., DeRose J., Wallach S. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment. J Clin Endocrinol Metab. 1976 Mar;42(3):459–463. doi: 10.1210/jcem-42-3-459. [DOI] [PubMed] [Google Scholar]
  6. Avramides A., Flores A., Derose J., Wallach S. Treatment of Paget's disease of bone with once a week injections of salmon calcitonin. Br Med J. 1975 Sep 13;3(5984):632–632. doi: 10.1136/bmj.3.5984.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Avramides A. Salmon and porcine calcitonin treatment of Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):78–85. [PubMed] [Google Scholar]
  8. Bell N. H., Avery S., Johnston C. C., Jr Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia. J Clin Endocrinol Metab. 1970 Sep;31(3):283–290. doi: 10.1210/jcem-31-3-283. [DOI] [PubMed] [Google Scholar]
  9. Bijvoet O. L., Hosking D. J., Van Aken J., Will E. J. Calcitonin or EHDP in Paget's disease? Calcif Tissue Res. 1977 May;22 (Suppl):494–494. doi: 10.1007/BF02064140. [DOI] [PubMed] [Google Scholar]
  10. Bijvoet O. L., van der Sluys Veer J., Jansen A. P. Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia. Lancet. 1968 Apr 27;1(7548):876–881. doi: 10.1016/s0140-6736(68)90236-5. [DOI] [PubMed] [Google Scholar]
  11. Bijvoet O. L., van der Sluys Veer J., de Vries H. R., van Koppen A. T. Natriuretic effect of calcitonin in man. N Engl J Med. 1971 Apr 1;284(13):681–688. doi: 10.1056/NEJM197104012841301. [DOI] [PubMed] [Google Scholar]
  12. Burckhardt P. M., Singer F. R., Potts J. T., Jr Parathyroid function in patients with Paget's disease treated with salmon calcitonin. Clin Endocrinol (Oxf) 1973 Jan;2(1):15–22. doi: 10.1111/j.1365-2265.1973.tb03480.x. [DOI] [PubMed] [Google Scholar]
  13. COLLINS D. H. Paget's disease of bone; incidence and subclinical forms. Lancet. 1956 Jul 14;271(6933):51–57. doi: 10.1016/s0140-6736(56)90422-6. [DOI] [PubMed] [Google Scholar]
  14. Canfield R., Rosner W., Skinner J., McWhorter J., Resnick L., Feldman F., Kammerman S., Ryan K., Kunigonis M., Bohne W. Diphosphonate therapy of paget's disease of bone. J Clin Endocrinol Metab. 1977 Jan;44(1):96–106. doi: 10.1210/jcem-44-1-96. [DOI] [PubMed] [Google Scholar]
  15. Christiansen C., Tonnesen K. H. Zinc-protamine-glucagon in the treatment of Paget's disease of bone. Preliminary report. Acta Med Scand. 1974 Dec;196(6):495–496. doi: 10.1111/j.0954-6820.1974.tb01048.x. [DOI] [PubMed] [Google Scholar]
  16. Condon J. R. Glucagon in the treatment of Paget's disease of bone. Br Med J. 1971 Dec 18;4(5789):719–721. doi: 10.1136/bmj.4.5789.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Condon J. R., Reith S. B., Nassim J. R., Millard F. J., Hilb A., Stainthorpe E. M. Treatment of Paget's disease of bone with mithramycin. Br Med J. 1971 Feb 20;1(5746):421–423. doi: 10.1136/bmj.1.5746.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Corcoran R. J., Reeder M. M. Enlargement of one or more vertebrae. JAMA. 1977 Oct 3;238(14):1555–1556. [PubMed] [Google Scholar]
  19. Crosbie W. A., Mohamedally S. M., Woodhouse N. J. Effect of salmon calcitonin on cardiac output, oxygen transport and bone turnover in patients with Paget's disease. Clin Sci Mol Med Suppl. 1975 Jun;48(6):537–540. doi: 10.1042/cs0480537. [DOI] [PubMed] [Google Scholar]
  20. DE DEUXCHAISNES C. N., KRANE S. M. PAGET'S DISEASE OF BONE: CLINICAL AND METABOLIC OBSERVATIONS. Medicine (Baltimore) 1964 May;43:233–266. [PubMed] [Google Scholar]
  21. De Vries H. R., Bijvoet O. L. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Neth J Med. 1974;17(6):281–298. [PubMed] [Google Scholar]
  22. DeRose J., Singer F. R., Avramides A., Flores A., Dziadiw R., Baker R. K., Wallach S. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment. Am J Med. 1974 Jun;56(6):858–866. doi: 10.1016/0002-9343(74)90815-8. [DOI] [PubMed] [Google Scholar]
  23. Doyle F. H., Pennock J., Greenberg P. B., Joplin G. F., MacIntyre I. Radiological evidence of a dose-related response to long-term treatment of Paget's disease with human calcitonin. Br J Radiol. 1974 Jan;47(553):1–8. doi: 10.1259/0007-1285-47-553-1. [DOI] [PubMed] [Google Scholar]
  24. EISENSTEIN R., PASSAVOY M. ACTINOMYCIN D INHIBITS PARATHYROID HORMONE AND VITAMIN D ACTIVITY. Proc Soc Exp Biol Med. 1964 Oct;117:77–79. doi: 10.3181/00379727-117-29501. [DOI] [PubMed] [Google Scholar]
  25. Evans G. A., Slee G. C. Calcitonin for multiple fractures in Paget's disease. Br Med J. 1977 Feb 5;1(6057):357–357. doi: 10.1136/bmj.1.6057.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Evans R. A. A cheap oral therapy for Paget's disease of bone. Calcif Tissue Res. 1977 May;22 (Suppl):287–291. doi: 10.1007/BF02064081. [DOI] [PubMed] [Google Scholar]
  27. Fast D. K., Felix R., Neuman W. F., Sallis J., Fleisch H. The effect of diphosphonates on cells in culture. Calcif Tissue Res. 1977 May;22 (Suppl):449–451. doi: 10.1007/BF02064126. [DOI] [PubMed] [Google Scholar]
  28. Fennelly J. J., Groarke J. F. Effect of actinomycin D on Paget's disease of bone. Br Med J. 1971 Feb 20;1(5746):423–426. doi: 10.1136/bmj.1.5746.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Finerman G. A., Gonick H. C., Smith R. K., Mayfield J. M. Diphosphonate treatment of Paget's disease. Clin Orthop Relat Res. 1976 Oct;(120):115–124. [PubMed] [Google Scholar]
  30. Fotino M., Haymovits A., Falk C. T. Evidence for linkage between HLA and Paget's disease. Transplant Proc. 1977 Dec;9(4):1867–1868. [PubMed] [Google Scholar]
  31. Francis M. J., Smith R. Evidence of a generalised connective-tissue defect in Paget's disease of bone. Lancet. 1974 May 4;1(7862):841–841. doi: 10.1016/s0140-6736(74)90487-5. [DOI] [PubMed] [Google Scholar]
  32. Franck W. A., Bress N. M., Singer F. R., Krane S. M. Rheumatic manifestations of Paget's disease of bone. Am J Med. 1974 May;56(5):592–603. doi: 10.1016/0002-9343(74)90629-9. [DOI] [PubMed] [Google Scholar]
  33. Friedman J., Raisz L. G. Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science. 1965 Dec 10;150(3702):1465–1467. doi: 10.1126/science.150.3702.1465. [DOI] [PubMed] [Google Scholar]
  34. Gardner W. J., Dohn D. F. Trigeminal neuralgia--hemifacial spasm--Paget's disease: significance of this association. Brain. 1966 Sep;89(3):555–562. doi: 10.1093/brain/89.3.555. [DOI] [PubMed] [Google Scholar]
  35. Genuth S. M., Klein L. Hypoparathyroidism and Paget's disease: the effect of parathyroid hormone administration. J Clin Endocrinol Metab. 1972 Nov;35(5):693–699. doi: 10.1210/jcem-35-5-693. [DOI] [PubMed] [Google Scholar]
  36. Gershberg H., Girgis M., Goldberg L., Duga J., St Paul H. The acute response to calcitonin in Paget's disease: its relationship to the serum alkaline phosphatase level and the effect of phosphate treatment. J Clin Endocrinol Metab. 1973 Apr;36(4):691–696. doi: 10.1210/jcem-36-4-691. [DOI] [PubMed] [Google Scholar]
  37. Goldman A. B., Braunstein P., Wilkinson D., Kammerman S. Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy. Radiology. 1975 Nov;117(2):365–369. doi: 10.1148/117.2.365. [DOI] [PubMed] [Google Scholar]
  38. Gordan G. S. Recent progress in calcium metabolism: clinical application. Calif Med. 1971 May;114(5):28–43. [PMC free article] [PubMed] [Google Scholar]
  39. Greenberg P. B., Doyle F. H., Fisher M. T., Hillyard C. J., Joplin G. F., Pennock J., MacIntyre I. Treatment of Paget's disease of bone with synthetic human calcitonin: biochemical and roentgenologic changes. Am J Med. 1974 Jun;56(6):867–870. doi: 10.1016/0002-9343(74)90816-x. [DOI] [PubMed] [Google Scholar]
  40. Grimaldi P. M., Mohamedally S. M., Woodhouse N. J. Deafness in Paget's diseases: effect of salmon calcitonin treatment. Br Med J. 1975 Jun 28;2(5973):726–726. doi: 10.1136/bmj.2.5973.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. HENNEMAN P. H., DULL T. A., AVIOLI L. V., BASTOMSKY C. H., LYNCH T. N. EFFECTS OF ASPIRIN AND CORTICOSTEROIDS ON PAGET'S DISEASE OF BONE. Trans Stud Coll Physicians Phila. 1963 Jul;31:10–25. [PubMed] [Google Scholar]
  42. HIGGINS B. A., NASSIM J. R., ALEXANDER R., HILB A. EFFECT OF SODIUM FLUORIDE ON CALCIUM, PHOSPHORUS, AND NITROGEN BALANCE IN PATIENTS WITH PAGET'S DISEASE. Br Med J. 1965 May 1;1(5443):1159–1161. doi: 10.1136/bmj.1.5443.1159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. HOWARTH S. Cardiac output in osteitis deformans. Clin Sci. 1953;12(3):271–275. [PubMed] [Google Scholar]
  44. Haddad J. G., Jr, Birge S. J., Avioli L. V. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone. N Engl J Med. 1970 Sep 10;283(11):549–555. doi: 10.1056/NEJM197009102831101. [DOI] [PubMed] [Google Scholar]
  45. Hadjipavlou A. G., Tsoukas G. M., Siller T. N., Danais S., Greenwood F. Combination drug therapy in treatment of Paget's disease of bone: clinical and metabolic response. J Bone Joint Surg Am. 1977 Dec;59(8):1045–1051. [PubMed] [Google Scholar]
  46. Hamilton C. R., Jr Effects of synthetic salmon calcitonin in patients with Paget's disease of bone. Am J Med. 1974 Mar;56(3):315–322. doi: 10.1016/0002-9343(74)90613-5. [DOI] [PubMed] [Google Scholar]
  47. Harrison C. V., Lennox B. HEART BLOCK IN OSTEITIS DEFORMANS. Br Heart J. 1948 Jul;10(3):167–176. doi: 10.1136/hrt.10.3.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hartman J. T., Dohn D. F. Paget's disease of the spine with cord or nerve-root compression. J Bone Joint Surg Am. 1966 Sep;48(6):1079–1084. [PubMed] [Google Scholar]
  49. Heistad D. D., Abboud F. M., Schmid P. G., Mark A. L., Wilson W. R. Regulation of blood flow in Paget's disease of bone. J Clin Invest. 1975 Jan;55(1):69–74. doi: 10.1172/JCI107919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Hosking D. J., Bijvoet O. L. Combined diphosphonate and calcitonin therapy for Paget's disease of bone. Calcif Tissue Res. 1976 Aug;21 (Suppl):321–326. [PubMed] [Google Scholar]
  51. Jones J. V., Reed M. F. Paget's disease: a family with six cases. Br Med J. 1967 Oct 14;4(5571):90–91. doi: 10.1136/bmj.4.5571.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Kanis J. A., Fitzpatrick K., Strong J. A. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses. Q J Med. 1975 Jul;44(175):399–413. [PubMed] [Google Scholar]
  53. Kanis J. A., Horn D. B., Scott R. D., Strong J. A. Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br Med J. 1974 Sep 21;3(5933):727–731. doi: 10.1136/bmj.3.5933.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Khairi M. R., Altman R. D., DeRosa G. P., Zimmermann J., Schenk R. K., Johnston C. C. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. Ann Intern Med. 1977 Dec;87(6):656–663. doi: 10.7326/0003-4819-87-6-656. [DOI] [PubMed] [Google Scholar]
  55. Khairi M. R., Wellman H. N., Robb J. A., Johnston C. C., Jr Paget's disease of bone (osteitis deformans): symptomatic lesions and bone scan. Ann Intern Med. 1973 Sep;79(3):348–351. doi: 10.7326/0003-4819-79-3-348. [DOI] [PubMed] [Google Scholar]
  56. Krane S. M., Harris E. D., Jr, Singer F. R., Potts J. T., Jr Acute effects of calcitonin on bone formation in man. Metabolism. 1973 Jan;22(1):51–58. doi: 10.1016/0026-0495(73)90028-0. [DOI] [PubMed] [Google Scholar]
  57. Krane S. M., Kantrowitz F. G., Byrne M., Pinnell S. R., Singer F. R. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. J Clin Invest. 1977 May;59(5):819–827. doi: 10.1172/JCI108704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Krane S. M., Muñoz A. J., Harris E. D., Jr Collagen-like fragments: excretion in urine of patients with Paget's disease of bone. Science. 1967 Aug 11;157(3789):713–716. doi: 10.1126/science.157.3789.713. [DOI] [PubMed] [Google Scholar]
  59. Krane S. M. Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):24–36. [PubMed] [Google Scholar]
  60. LAKE M. Studies of Paget's disease (osteitis deformans). J Bone Joint Surg Br. 1951 Aug;33-B(3):323–335. doi: 10.1302/0301-620X.33B3.323. [DOI] [PubMed] [Google Scholar]
  61. LUXTON R. W. Paget's disease of bone associated with Hashimoto's struma lymphomatosa; a clue to the pathogenesis of Paget's disease? Lancet. 1957 Mar 2;272(6966):441–443. doi: 10.1016/s0140-6736(57)90519-6. [DOI] [PubMed] [Google Scholar]
  62. Lavender J. P., Evans I. M., Arnot R., Bowring S., Doyle F. H., Joplin G. F., MacIntyre I. A comparison of radiography and radioisotope scanning in the detection of Paget's disease and in the assessment of response to human calcitonin. Br J Radiol. 1977 Apr;50(592):243–250. doi: 10.1259/0007-1285-50-592-243. [DOI] [PubMed] [Google Scholar]
  63. Lebbin D., Ryan W. G., Schwartz T. B. Outpatient treatment of Paget's disease of bone with mithramycin. Ann Intern Med. 1974 Nov;81(5):635–637. doi: 10.7326/0003-4819-81-5-635. [DOI] [PubMed] [Google Scholar]
  64. Lentle B. C., Russell A. S., Heslip P. G., Percy J. S. The scintigraphic findings in Paget's disease of bone. Clin Radiol. 1976 Jan;27(1):129–135. doi: 10.1016/s0009-9260(76)80037-2. [DOI] [PubMed] [Google Scholar]
  65. MARSHALL T. R., LING J. T. THE BRIM SIGN; A NEW SIGN FOUND IN PAGET'S DISEASE (OSTEITIS DEFORMANS) OF THE PELVIS. Am J Roentgenol Radium Ther Nucl Med. 1963 Dec;90:1267–1270. [PubMed] [Google Scholar]
  66. MAURICE P. F., LYNCH T. N., BASTOMSKY C. H., DULL T. A., AVIOLI L. V., HENNEMAN P. H. Metabolic evidence for suppression of Paget's disease of bone by aspirin. Trans Assoc Am Physicians. 1962;75:208–219. [PubMed] [Google Scholar]
  67. MCKENNA R. J., SCHWINN C. P., SOONG K. Y., HIGINBOTHAM N. L. OSTEOGENIC SARCOMA ARISING IN PAGET'S DISEASE. Cancer. 1964 Jan;17:42–66. doi: 10.1002/1097-0142(196401)17:1<42::aid-cncr2820170108>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  68. MOORE S. Osteitis deformans; a theory of its etiology. J Bone Joint Surg Am. 1951 Apr;33-A(2):421–430. [PubMed] [Google Scholar]
  69. Melick R. A., Ebeling P., Hjorth R. J. Improvement in paraplegia in vertebral Paget's disease treated with calcitonin. Br Med J. 1976 Mar 13;1(6010):627–628. doi: 10.1136/bmj.1.6010.627-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Melick R. A., Martin T. J. Paget's disease in identical twins. Aust N Z J Med. 1975 Dec;5(6):564–565. doi: 10.1111/j.1445-5994.1975.tb03864.x. [DOI] [PubMed] [Google Scholar]
  71. Milgram J. W. Orthopedic management of Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):63–69. [PubMed] [Google Scholar]
  72. Mills B. G., Singer F. R. Nuclear inclusions in Paget's disease of bone. Science. 1976 Oct 8;194(4261):201–202. doi: 10.1126/science.959849. [DOI] [PubMed] [Google Scholar]
  73. Minkin C. Inhibition of parathyroid hormone stimulated bone resorption in vitro by the antibiotic mithramycin. Calcif Tissue Res. 1973 Dec 31;13(4):249–257. doi: 10.1007/BF02015415. [DOI] [PubMed] [Google Scholar]
  74. Misra D. P. Crosslink in bone collagen in Paget's disease. J Clin Pathol. 1975 Apr;28(4):305–308. doi: 10.1136/jcp.28.4.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Mundy G. R., Raisz L. G. Drugs for disorders of bone: pharmacological and clinical considerations. Drugs. 1974;8(4):250–289. doi: 10.2165/00003495-197408040-00003. [DOI] [PubMed] [Google Scholar]
  76. Nager G. T. Paget's disease of the temporal bone. Ann Otol Rhinol Laryngol. 1975 Jul-Aug;84(4 Pt 3 Suppl 22):1–32. doi: 10.1177/0003489475084S2201. [DOI] [PubMed] [Google Scholar]
  77. Naiken V. S. Did Beethoven have Paget's disease of bone? Ann Intern Med. 1971 Jun;74(6):995–999. doi: 10.7326/0003-4819-74-6-995. [DOI] [PubMed] [Google Scholar]
  78. OJEMANN R. G., JAIN K. K. CAROTID BLOOD FLOW IN PAGET'S DISEASE OF THE SKULL. A STUDY WITH ELECTROMAGNETIC FLOWMETER. J Neurosurg. 1963 Jun;20:471–473. doi: 10.3171/jns.1963.20.6.0471. [DOI] [PubMed] [Google Scholar]
  80. PURVES M. J. Some effects of administering sodium fluoride to patients with Paget's disease. Lancet. 1962 Dec 8;2(7267):1188–1189. doi: 10.1016/s0140-6736(62)90958-3. [DOI] [PubMed] [Google Scholar]
  81. PYGOTT F. Paget's disease of bone; the radiological incidence. Lancet. 1957 Jun 8;272(6980):1170–1171. doi: 10.1016/s0140-6736(57)91738-5. [DOI] [PubMed] [Google Scholar]
  82. Pembrook R. C., Chung C. H., Carvallo A. P. Effects of mithramycin and calcitonin in cardiovascular complications of Paget's disease of bone. Conn Med. 1975 Apr;39(4):209–214. [PubMed] [Google Scholar]
  83. RAPAPORT E., KUIDA H., DEXTER L., HENNEMAN P. H., ALBRIGHT F. The cardiac output in Paget's disease before and after treatment with cortisone. Am J Med. 1957 Feb;22(2):252–257. doi: 10.1016/0002-9343(57)90008-6. [DOI] [PubMed] [Google Scholar]
  84. RICH C., ENSINCK J., IVANOVICH P. THE EFFECTS OF SODIUM FLORIDE ON CALCIUM METABOLISM OF SUBJECTS WITH METABOLIC BONE DISEASES. J Clin Invest. 1964 Apr;43:545–555. doi: 10.1172/JCI104940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. ROSENKRANTZ J. A., WOLF J., KAICHER J. J. Paget's disease (osteitis deformans); review of one hundred eleven cases. AMA Arch Intern Med. 1952 Nov;90(5):610–633. doi: 10.1001/archinte.1952.00240110036005. [DOI] [PubMed] [Google Scholar]
  86. Rashid M., Khairi A., Johnston C., Jr Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP). Clin Orthop Relat Res. 1977;(127):94–105. [PubMed] [Google Scholar]
  87. Rasmussen H., Bordier P. The cellular basis of metabolic bone disease. N Engl J Med. 1973 Jul 5;289(1):25–32. doi: 10.1056/NEJM197307052890107. [DOI] [PubMed] [Google Scholar]
  88. Rebel A., Malkani K., Baslé M., Bregeon C. Is Paget's disease of bone a viral infection? Calcif Tissue Res. 1977 May;22 (Suppl):283–286. doi: 10.1007/BF02064080. [DOI] [PubMed] [Google Scholar]
  89. Rhodes B. A., Greyson N. D., Hamilton C. R., Jr, White R. I., Jr, Giargiana F. A., Jr, Wagner H. N., Jr Absence of anatomic arteriovenous shunts in Paget's disease of bone. N Engl J Med. 1972 Oct 5;287(14):686–689. doi: 10.1056/NEJM197210052871403. [DOI] [PubMed] [Google Scholar]
  90. Rojanasathit S., Rosenberg E., Haddad J. G., Jr Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin. Lancet. 1974 Dec 14;2(7894):1412–1415. doi: 10.1016/s0140-6736(74)90072-5. [DOI] [PubMed] [Google Scholar]
  91. Russell R. G., Smith R., Preston C., Walton R. J., Woods C. G. Diphosphonates in Paget's disease. Lancet. 1974 May 11;1(7863):894–898. doi: 10.1016/s0140-6736(74)90347-x. [DOI] [PubMed] [Google Scholar]
  92. Ryan W. G., Schwartz T. B., Northrop G. Experiences in the treatment of Paget's disease of bone with mithramycin. JAMA. 1970 Aug 17;213(7):1153–1157. [PubMed] [Google Scholar]
  93. Ryan W. G., Schwartz T. B., Perlia C. P. Effects of mithramycin on Paget's disease of bone. Ann Intern Med. 1969 Mar;70(3):549–557. doi: 10.7326/0003-4819-70-3-549. [DOI] [PubMed] [Google Scholar]
  94. Ryan W. G. Treatment of Paget's disease of bone with mithramycin. Clin Orthop Relat Res. 1977;(127):106–110. [PubMed] [Google Scholar]
  95. STEINBACH H. L. Some roentgen features of Paget's disease. Am J Roentgenol Radium Ther Nucl Med. 1961 Nov;86:950–964. [PubMed] [Google Scholar]
  96. STORSTEEN K. A., JANES J. M. Arteriography and vascular studies in Paget's disease of bone. J Am Med Assoc. 1954 Feb 6;154(6):472–474. doi: 10.1001/jama.1954.02940400010003. [DOI] [PubMed] [Google Scholar]
  97. Schmidek H. H. Neurologic and neurosurgical sequelae of Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):70–77. [PubMed] [Google Scholar]
  98. Sekel R. Calcium infusion in painful Paget's disease of bone. Lancet. 1973 Feb 17;1(7799):372–373. doi: 10.1016/s0140-6736(73)90162-1. [DOI] [PubMed] [Google Scholar]
  99. Shai F., Baker R. K., Wallach S. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone. J Clin Invest. 1971 Sep;50(9):1927–1940. doi: 10.1172/JCI106685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Shirazi P. H., Ryan W. G., Fordham E. W. Bone scanning in evaluation of Paget's disease of bone. CRC Crit Rev Clin Radiol Nucl Med. 1974 Oct;5(4):523–558. [PubMed] [Google Scholar]
  101. Singer F. R., Aldred J. P., Neer R. M., Krane S. M., Potts J. T., Jr, Bloch K. J. An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest. 1972 Sep;51(9):2331–2338. doi: 10.1172/JCI107044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Singer F. R. Human calcitonin treatment of Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):86–93. [PubMed] [Google Scholar]
  103. Singer F. R., Melvin K. E., Mills B. G. Acute effects of calcitonin on osteoclasts in man. Clin Endocrinol (Oxf) 1976;5 (Suppl):333S–340S. doi: 10.1111/j.1365-2265.1976.tb03842.x. [DOI] [PubMed] [Google Scholar]
  104. Smith R., Russell R. G., Bishop M. C., Woods C. G., Bishop M. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment. Q J Med. 1973 Apr;42(166):235–256. [PubMed] [Google Scholar]
  105. Solomon L. R., Evanson J. M., Canty D. P., Gill N. W. Effect of calcitonin treatment on deafness due to Paget's disease of bone. Br Med J. 1977 Aug 20;2(6085):485–487. doi: 10.1136/bmj.2.6085.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Somayaji B. N. Malabsorption syndrome in Paget's disease of bone. Br Med J. 1968 Nov 2;4(5626):278–280. doi: 10.1136/bmj.4.5626.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Somerville P. J., Evans R. A. Actinomycin D in the treatment of Paget's disease of bone. Med J Aust. 1975 Jul 5;2(1):13–16. doi: 10.5694/j.1326-5377.1975.tb95071.x. [DOI] [PubMed] [Google Scholar]
  108. Sparrow N. L., Duvall A. J., 3rd Hearing loss and Paget's disease. J Laryngol Otol. 1967 Jun;81(6):601–611. doi: 10.1017/s0022215100067542. [DOI] [PubMed] [Google Scholar]
  109. Stein I., Shapiro B., Ostrum B., Beller M. L. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans. Clin Orthop Relat Res. 1977 Jan-Feb;(122):347–358. [PubMed] [Google Scholar]
  110. Steinbach H. L., Dodds W. J. Clinical radiology of Paget's disease. Clin Orthop Relat Res. 1968 Mar-Apr;57:277–297. [PubMed] [Google Scholar]
  111. The classic. Paget's disease of bone: Henry L. Jaffe. Archives of Pathology 15:83, 1933. Clin Orthop Relat Res. 1977;(127):4–23. [PubMed] [Google Scholar]
  112. WOODARD H. Q. Long term studies of the blood chemistry in Paget's disease of bone. Cancer. 1959 Nov-Dec;12:1226–1237. doi: 10.1002/1097-0142(195911/12)12:6<1226::aid-cncr2820120617>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  113. Walton R. J., Smith R., Russell R. G. Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets. Calcif Tissue Res. 1976 Aug;21 (Suppl):339–343. [PubMed] [Google Scholar]
  114. Waxman A. D., Ducker S., McKee D., Siemsen J. K., Singer F. R. Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment. Radiology. 1977 Dec;125(3):761–764. doi: 10.1148/125.3.761. [DOI] [PubMed] [Google Scholar]
  115. Wellman H. N., Schauwecker D., Robb J. A., Khairi M. R., Johnston C. C. Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease. Clin Orthop Relat Res. 1977;(127):55–62. [PubMed] [Google Scholar]
  116. Welsh R. A., Meyer A. T. Nuclear fragmentations and associated fibrils in giant cell tumor of bone. Lab Invest. 1970 Jan;22(1):63–72. [PubMed] [Google Scholar]
  117. Wilgram J. W. Radiographical and pathological assessment of the activity of Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):43–54. [PubMed] [Google Scholar]
  118. Woodhouse N. J., Bordier P., Fisher M., Joplin G. F., Reiner M., Kalu D. N., Foster G. V., MacIntyre I. Human calcitonin in the treatment of Paget's bone disease. Lancet. 1971 Jun 5;1(7710):1139–1143. doi: 10.1016/s0140-6736(71)91657-6. [DOI] [PubMed] [Google Scholar]
  119. Woodhouse N. J., Chalmers A. H., Wells I. P., Dewbury K. C., Mohamedally S. M. Paget's disease. Radiological changes occurring in untreated patients and those on therapy with salmon calcitonin during two years' observation. Br J Radiol. 1977 Oct;50(598):699–705. doi: 10.1259/0007-1285-50-598-699. [DOI] [PubMed] [Google Scholar]
  120. Woodhouse N. J., Crosbie W. A., Mohamedally S. M. Cardiac output in Paget's disease: response to long-term salmon calcitonin therapy. Br Med J. 1975 Dec 20;4(5998):686–686. doi: 10.1136/bmj.4.5998.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Woodhouse N. J., Joplin G. F., MacIntyre I., Doyle F. H. Radiological regression in Paget's disease treated by human calcitonin. Lancet. 1972 Nov 11;2(7785):992–994. doi: 10.1016/s0140-6736(72)92404-x. [DOI] [PubMed] [Google Scholar]
  122. Woodhouse N. J., Mohamedally S. M., Saed-Nejad F., Martin T. J. Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment. Br Med J. 1977 Oct 8;2(6092):927–929. doi: 10.1136/bmj.2.6092.927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Wootton R., Reeve J., Spellacy E., Tellez-Yudilevich M. Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy. Clin Sci Mol Med. 1978 Jan;54(1):69–74. doi: 10.1042/cs0540069. [DOI] [PubMed] [Google Scholar]
  124. Wootton R., Reeve J., Veall N. Measurement of skeletal blood flow in normal man and in patients with Paget's disease of bone. Calcif Tissue Res. 1976 Aug;21 (Suppl):380–385. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES